BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2263671)

  • 1. Pharmacological characterization of ear-scratch response in mice as a behavioral model for selective 5-HT2-receptor agonists and evidence for 5-HT1B- and 5-HT2-receptor interactions.
    Darmani NA; Martin BR; Pandey U; Glennon RA
    Pharmacol Biochem Behav; 1990 Sep; 37(1):95-9. PubMed ID: 2263671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do functional relationships exist between 5-HT1A and 5-HT2 receptors?
    Darmani NA; Martin BR; Pandey U; Glennon RA
    Pharmacol Biochem Behav; 1990 Aug; 36(4):901-6. PubMed ID: 2145593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radioligand binding evidence implicates the brain 5-HT2 receptor as a site of action for LSD and phenylisopropylamine hallucinogens.
    Titeler M; Lyon RA; Glennon RA
    Psychopharmacology (Berl); 1988; 94(2):213-6. PubMed ID: 3127847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The head-twitch response in the least shrew (Cryptotis parva) is a 5-HT2- and not a 5-HT1C-mediated phenomenon.
    Darmani NA; Mock OB; Towns LC; Gerdes CF
    Pharmacol Biochem Behav; 1994 Jun; 48(2):383-96. PubMed ID: 8090805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selectivity of serotonergic drugs for multiple brain serotonin receptors. Role of [3H]-4-bromo-2,5-dimethoxyphenylisopropylamine ([3H]DOB), a 5-HT2 agonist radioligand.
    Titeler M; Lyon RA; Davis KH; Glennon RA
    Biochem Pharmacol; 1987 Oct; 36(19):3265-71. PubMed ID: 3663239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioural evidence for functional interactions between 5-HT-receptor subtypes in rats and mice.
    Berendsen HH; Broekkamp CL
    Br J Pharmacol; 1990 Nov; 101(3):667-73. PubMed ID: 2150180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LSD and the phenethylamine hallucinogen DOI are potent partial agonists at 5-HT2A receptors on interneurons in rat piriform cortex.
    Marek GJ; Aghajanian GK
    J Pharmacol Exp Ther; 1996 Sep; 278(3):1373-82. PubMed ID: 8819525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioral effects of (+/-)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane, (DOI) in the elevated plus-maze test.
    Onaivi ES; Bishop-Robinson C; Darmani NA; Sanders-Bush E
    Life Sci; 1995 Nov; 57(26):2455-66. PubMed ID: 8847967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the inhibitory adrenergic alpha 2 and serotonergic 5-HT1A components of cocaine's actions on the DOI-induced head-twitch response in 5-HT2-receptor supersensitive mice.
    Darmani NA
    Pharmacol Biochem Behav; 1993 Jun; 45(2):269-74. PubMed ID: 8392199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of 5-HT2 receptors in rat cortex. Studies with a putative selective agonist and an antagonist.
    Pranzatelli MR
    Biochem Pharmacol; 1991 Aug; 42(5):1099-105. PubMed ID: 1872895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repeated administration of low doses of cocaine enhances the sensitivity of 5-HT2 receptor function.
    Darmani NA; Martin BR; Glennon RA
    Pharmacol Biochem Behav; 1992 Mar; 41(3):519-27. PubMed ID: 1584831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotonin-dependent collagenase induction in rat myometrial smooth muscle cells: mediation by the 5-HT2 receptor.
    Rydelek-Fitzgerald L; Wilcox BD; Teitler M; Jeffrey JJ
    Mol Cell Endocrinol; 1993 Feb; 91(1-2):67-74. PubMed ID: 8472855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of the 5-HT2 receptor in the 5-HT receptor-mediated stimulation of prolactin release.
    Albinsson A; Palazidou E; Stephenson J; Andersson G
    Eur J Pharmacol; 1994 Jan; 251(2-3):157-61. PubMed ID: 8149973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoradiographic characterization of (+-)-1-(2,5-dimethoxy-4-[125I] iodophenyl)-2-aminopropane ([125I]DOI) binding to 5-HT2 and 5-HT1c receptors in rat brain.
    Appel NM; Mitchell WM; Garlick RK; Glennon RA; Teitler M; De Souza EB
    J Pharmacol Exp Ther; 1990 Nov; 255(2):843-57. PubMed ID: 2243353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Further evidence for enigmas in adaptation mechanisms for the DOI-induced behaviors.
    Darmani NA
    Pharmacol Biochem Behav; 1992 Nov; 43(3):765-70. PubMed ID: 1448470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A behavioural and biochemical study in mice and rats of putative selective agonists and antagonists for 5-HT1 and 5-HT2 receptors.
    Goodwin GM; Green AR
    Br J Pharmacol; 1985 Mar; 84(3):743-53. PubMed ID: 2580582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. L-5-HTP facilitates the electrically stimulated flexor reflex in pithed rats: evidence for 5-HT2-receptor mediation.
    Skarsfeldt T; Arnt J; Hyttel J
    Eur J Pharmacol; 1990 Feb; 176(2):135-42. PubMed ID: 1968846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological characterization of serotonin receptor subtypes involved in vasopressin and plasma renin activity responses to serotonin agonists.
    Bagdy G; Sved AF; Murphy DL; Szemeredi K
    Eur J Pharmacol; 1992 Jan; 210(3):285-9. PubMed ID: 1535317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential actions of serotonin antagonists on two behavioral models of serotonin receptor activation in the rat.
    Lucki I; Nobler MS; Frazer A
    J Pharmacol Exp Ther; 1984 Jan; 228(1):133-9. PubMed ID: 6694097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-HT1A and 5-HT2 receptors mediate discrete behaviors in the Mongolian gerbil.
    Eison AS; Wright RN
    Pharmacol Biochem Behav; 1992 Sep; 43(1):131-7. PubMed ID: 1409796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.